GLP-1 Receptor Agonists: The Foundation of Modern Weight Loss Medications GLP-1 receptor agonists are synthetic compounds that mimic the effects of GLP-1 but with much longer half-lives, allowing for daily or even weekly dosing
By slowing down digestion and reducing cravings, Semaglutide makes it easier for people to eat less and, over time, lose weight
Each serving delivers 7g of dietary fiber, 3g of which is soluble fiber (the type that ferments in the gut, feeds the microbiome, and drives the short-chain fatty acid production linked to GLP-1 activity)
Novo poured money into the technology, and by 1987, it succeeded in making recombinant human insulin using yeast cells that had been genetically modified
Complete rest often proves counterproductive for tendon and muscle problems, but continuing aggravating activities impairs healing regardless of peptide support
Contrave, approved in 2014, combines naltrexone and bupropion through a different mechanism than newer agents like Mounjaro, which activates both GLP-1 and GIP receptors to produce stronger metabolic effects